BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37408575)

  • 1. Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism.
    Dou L; Lu E; Tian D; Li F; Deng L; Zhang Y
    J Transl Int Med; 2023 Jul; 11(2):169-177. PubMed ID: 37408575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S; Ji X; Wang R; Miao Y
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells.
    Wang Z; Chen W; Zuo L; Xu M; Wu Y; Huang J; Zhang X; Li Y; Wang J; Chen J; Wang H; Sun H
    Cancer Commun (Lond); 2022 Mar; 42(3):245-265. PubMed ID: 35234370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
    Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer.
    Yu X; Zhang X; Wang G; Wang B; Ding Y; Zhao J; Liu H; Cui S
    Cancer Cell Int; 2020 Nov; 20(1):534. PubMed ID: 33292230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
    Li N; Li H; Wang Y; Cao L; Zhan X
    EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
    Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
    Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.
    Zhuang L; Zhang B; Liu X; Lin L; Wang L; Hong Z; Chen J
    Cell Biol Int; 2021 Oct; 45(10):2140-2149. PubMed ID: 34288231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
    Wang D; You D; Li L
    J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RPL23 restores chemosensitivity of cisplatin-resistant ovarian carcinoma by inhibiting EMT.
    Liu Y; Lai S; He J; Wan J; Fu F; Jinlong Y
    Cytotechnology; 2022 Jun; 74(3):421-432. PubMed ID: 35733701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
    Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
    Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
    [No Abstract]   [Full Text] [Related]  

  • 17. EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells.
    Poursheikhani A; Yousefi H; Tavakoli-Bazzaz J; Seyed H G
    Iran Biomed J; 2020 Nov; 24(6):370-8. PubMed ID: 32660222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.
    Wang Y; Yan C; Qi J; Liu C; Yu J; Wang H
    Mol Cell Biochem; 2022 Jan; 477(1):307-317. PubMed ID: 34716858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway.
    Zou Y; Zhao Z; Wang J; Ma L; Liu Y; Sun L; Song Y
    Int J Biol Sci; 2023; 19(10):3099-3114. PubMed ID: 37416779
    [No Abstract]   [Full Text] [Related]  

  • 20. NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer.
    Zhu J; Wu G; Song L; Cao L; Tan Z; Tang M; Li Z; Shi D; Zhang S; Li J
    EBioMedicine; 2019 May; 43():238-252. PubMed ID: 31047858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.